They also fit with recent modeling of the effects of SGLT2 inhibition in animals with diabetes suggesting that acute and chronic SGLT2 inhibition should decrease active oxygen consumption in the cortex by about 30% due to the reduction of the hyperfiltration that lowers proximal tubule active sodium transport [6]. Here, SLC5A2 is linked to diabetes mellitus.